Fentanyl Cit 200mcg Tablets

Manufacturer MAYNE PHARMA Active Ingredient Fentanyl Buccal Tablet(FEN ta nil) Pronunciation FEN-ta-nil
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life-threatening if not treated. @ COMMON USES: It is used to manage pain.This drug is not for mild pain or pain that only lasts a short time (like headaches, toothaches, or pain after surgery).This drug is only for use by people who have been taking pain drugs (opioids) and are used to their effects. Talk with the doctor.
🏷️
Drug Class
Opioid Analgesic
🧬
Pharmacologic Class
Opioid Agonist
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Sep 2006
βš–οΈ
DEA Schedule
Schedule II

Overview

ℹ️

What is this medicine?

Fentanyl buccal tablets are a strong opioid pain medicine used only for breakthrough cancer pain in patients who are already taking and are tolerant to other around-the-clock opioid pain medicines. It works by changing how your brain and nervous system respond to pain. It is placed in your mouth, either between your gum and cheek or under your tongue, where it dissolves and is absorbed.
πŸ“‹

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided.

1. Administration: Place the tablet in your mouth, above a rear molar tooth, between your upper cheek and gum. Allow it to dissolve completely. Alternatively, you can place it under your tongue and let it dissolve. Do not chew, break, or crush the tablet.
2. Dissolution: Do not eat or drink until the tablet has dissolved completely. If the tablet has not dissolved after 30 minutes, you can swallow the remaining portion with water.
3. Alternating Sides: With each dose, alternate the side of your mouth where you place the tablet.

Storage and Disposal

1. Storage: Keep this medication at room temperature in a dry place, away from the bathroom.
2. Safety Precautions: Store the medication in a secure location, out of sight and reach of children and pets, and inaccessible to others. Consider using a locked box or area.
3. Disposal: Dispose of unused or expired medication properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so. Consult your pharmacist for guidance on the best disposal method, and inquire about potential drug take-back programs in your area.

Missed Dose

If you take this medication regularly and miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at once or extra doses. If you take this medication as needed, do not take it more frequently than directed by your doctor.
πŸ’‘

Lifestyle & Tips

  • Do not drive or operate heavy machinery until you know how this medicine affects you, as it can cause drowsiness and dizziness.
  • Avoid alcohol and other CNS depressants, as they can increase the risk of serious side effects like severe breathing problems and sedation.
  • Store this medication securely and out of reach of children and pets, as accidental exposure can be fatal.
  • Do not share this medication with anyone else.
  • Follow the instructions for administration precisely; do not chew, crush, or swallow the tablet whole.
  • Dispose of unused or expired tablets properly by flushing them down the toilet, as per the REMS program instructions, to prevent accidental exposure.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Initial dose: 100 mcg buccal tablet. Titrate upwards to an effective dose for breakthrough cancer pain (BTCP). Only for opioid-tolerant patients.
Dose Range: 100 - 1600 mg

Condition-Specific Dosing:

breakthroughCancerPain: Initial dose 100 mcg. Administer one tablet for each BTCP episode. Wait at least 4 hours before treating another episode with the same dose. If pain relief is inadequate after 30 minutes, a second dose of the same strength may be administered. Do not use more than 2 doses per BTCP episode. Titrate dose upwards in increments (e.g., 200, 400, 600, 800, 1200, 1600 mcg) until an effective dose is found. Limit to 4 doses per day once stable.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established in pediatric patients under 18 years of age.)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but monitor closely for signs of opioid toxicity.
Moderate: Use with caution; consider lower initial doses and slower titration. Monitor closely for signs of opioid toxicity.
Severe: Use with extreme caution; consider lower initial doses and slower titration. Monitor closely for signs of opioid toxicity. Fentanyl clearance may be reduced.
Dialysis: Fentanyl is not significantly removed by dialysis. Monitor closely for prolonged effects and toxicity.

Hepatic Impairment:

Mild: No specific dose adjustment recommended, but monitor closely for signs of opioid toxicity.
Moderate: Use with caution; consider lower initial doses and slower titration. Monitor closely for signs of opioid toxicity.
Severe: Use with extreme caution; consider lower initial doses and slower titration. Monitor closely for signs of opioid toxicity. Fentanyl clearance may be reduced.

Pharmacology

πŸ”¬

Mechanism of Action

Fentanyl is a potent opioid analgesic that acts primarily as an agonist at the mu-opioid receptors in the central nervous system (CNS). Its primary therapeutic action is analgesia. Other effects include respiratory depression, miosis, euphoria, and physical dependence.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 50% (buccal absorption, with some swallowed portion undergoing first-pass metabolism)
Tmax: 30-60 minutes (for buccal absorption)
FoodEffect: Food does not significantly affect the absorption of buccal fentanyl, but high-fat meals may slightly delay Tmax.

Distribution:

Vd: Approximately 4 L/kg
ProteinBinding: 80-85% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (highly lipophilic, readily crosses blood-brain barrier)

Elimination:

HalfLife: 3-7 hours (terminal half-life after buccal administration)
Clearance: Approximately 0.5 L/hr/kg
ExcretionRoute: Primarily urine (75% as metabolites, <10% as unchanged drug), feces (9% as metabolites)
Unchanged: <10%
⏱️

Pharmacodynamics

OnsetOfAction: 5-15 minutes (for buccal absorption)
PeakEffect: 20-60 minutes
DurationOfAction: 1-2 hours (for breakthrough pain relief)

Safety & Warnings

⚠️

BLACK BOX WARNING

RISK OF MEDICATION ERRORS, ADDICTION, ABUSE, AND MISUSE, REMS, RESPIRATORY DEPRESSION, ACCIDENTAL EXPOSURE, NEONATAL OPIOID WITHDRAWAL SYNDROME, and CYTOCHROME P450 3A4 INTERACTION.

* **Medication Errors:** Substantial differences in absorption exist between fentanyl products. Do not convert patients on a mcg per mcg basis from any other fentanyl product to Fentanyl Buccal Tablet. Initiate dosing with 100 mcg and titrate to effect.
* **Addiction, Abuse, and Misuse:** Fentanyl Buccal Tablet exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing Fentanyl Buccal Tablet, and monitor all patients receiving Fentanyl Buccal Tablet for the development of these behaviors or conditions.
* **REMS:** For all of these risks, Fentanyl Buccal Tablet is available only through a restricted program called the TIRF REMS Access program.
* **Respiratory Depression:** Serious, life-threatening, or fatal respiratory depression may occur. Monitor for respiratory depression, especially during initiation of Fentanyl Buccal Tablet or following a dose increase.
* **Accidental Exposure:** Accidental exposure to Fentanyl Buccal Tablet, especially in children, can result in a fatal overdose.
* **Neonatal Opioid Withdrawal Syndrome:** Prolonged use of Fentanyl Buccal Tablet during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.
* **CYP3A4 Interaction:** Concomitant use with all CYP3A4 inhibitors (e.g., ketoconazole, macrolide antibiotics, and ritonavir) can result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used CYP3A4 inducer may result in an increase in fentanyl plasma concentration. Monitor patients receiving Fentanyl Buccal Tablet and any CYP3A4 inhibitor or inducer.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following signs or symptoms, contact your doctor or seek immediate medical attention:

Allergic reaction symptoms, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or fainting
Confusion
Severe constipation or stomach pain, which may indicate a severe bowel problem
Breathing difficulties, such as:
+ Trouble breathing
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Chest pain
Abnormal heartbeat (fast or slow)
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Changes in eyesight
Mouth sores
Swelling in the feet or hands

Serotonin Syndrome: A Rare but Serious Condition

If you take this medication with certain other drugs, you may be at risk of developing serotonin syndrome, a potentially life-threatening condition. Seek medical help immediately if you experience:

Agitation
Balance problems
Confusion
Hallucinations
Fever
Abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea
Upset stomach
Vomiting
Severe headache

Adrenal Gland Problems: A Rare but Serious Condition

Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Seek medical help immediately if you experience:

Extreme fatigue or weakness
Fainting
Severe dizziness
Upset stomach
Vomiting
Decreased appetite

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following possible side effects:

Dizziness
Drowsiness
Fatigue
Weakness
Dry mouth
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Headache
Feeling cold
Sleep disturbances
Excessive sweating
Irritation at the site of administration
* Mouth tingling

If you experience any of these side effects or any other unusual symptoms, contact your doctor for advice. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow or shallow breathing
  • Extreme drowsiness or difficulty waking up
  • Dizziness or lightheadedness when standing up
  • Confusion
  • Pinpoint pupils
  • Bluish lips or skin
  • Severe constipation
  • Signs of allergic reaction (rash, hives, swelling of face/lips/tongue, difficulty breathing)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems, such as asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel blockage or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
Current use of certain medications, such as buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
Presence of mouth sores, which may require discussion with your doctor

This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you are experiencing. This will enable them to verify the safety of taking this medication in conjunction with your other medications and health conditions. Do not initiate, discontinue, or modify the dosage of any medication without consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying down position, and be cautious when climbing stairs.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and you may need higher doses to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed dose.

Additionally, regular use of opioid medications like this one can cause dependence. If you need to lower your dose or stop taking this medication, consult your doctor first, as sudden changes can increase the risk of withdrawal or other severe problems. Follow your doctor's instructions carefully, and report any increased pain, mood changes, suicidal thoughts, or other adverse effects.

Safe Use Guidelines
Do not exceed the prescribed dose, frequency, or duration of treatment, as this can increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.

If your pain worsens, you become more sensitive to pain, or you experience new pain after taking this medication, contact your doctor immediately. Do not take more than the prescribed dose.

Interactions and Precautions
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this can lead to unsafe and potentially deadly effects.

Seizure Risk
This medication may increase the risk of seizures in some individuals, particularly those with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.

Hormonal Effects
Long-term use of opioid medications like this one can lead to lower sex hormone levels. If you experience a decreased interest in sex, fertility problems, irregular menstrual periods, or ejaculation problems, contact your doctor.

Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, inform your doctor, as this medication can pass into breast milk and harm your baby. Seek medical attention immediately if your baby appears overly sleepy, limp, or has breathing difficulties.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Slowed or stopped breathing
  • Extreme drowsiness or unresponsiveness
  • Cold, clammy skin
  • Pinpoint pupils
  • Limp muscles
  • Bluish discoloration of lips and fingernails
  • Loss of consciousness

What to Do:

Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Call 1-800-222-1222 (Poison Control Center) for additional guidance.

Drug Interactions

🚫

Contraindicated Interactions

  • Concomitant use with CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, verapamil, diltiazem, grapefruit juice) due to increased fentanyl plasma concentrations and risk of respiratory depression.
  • Patients who are not opioid tolerant.
  • Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment.
  • Significant respiratory depression.
  • Known or suspected paralytic ileus.
πŸ”΄

Major Interactions

  • CNS depressants (e.g., benzodiazepines, other opioids, alcohol, sedatives, hypnotics, general anesthetics, phenothiazines, tranquilizers, skeletal muscle relaxants): Increased risk of respiratory depression, profound sedation, coma, and death.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol, linezolid, methylene blue): Risk of serotonin syndrome.
  • Mixed agonist/antagonist and partial agonist opioids (e.g., buprenorphine, nalbuphine, pentazocine): May reduce the analgesic effect of fentanyl and/or precipitate withdrawal symptoms.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): May decrease fentanyl plasma concentrations, leading to reduced efficacy or withdrawal symptoms.
🟑

Moderate Interactions

  • Anticholinergics: Increased risk of urinary retention and/or severe constipation.
  • Diuretics: Opioids may reduce the efficacy of diuretics by causing the release of antidiuretic hormone.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk for respiratory depression.

Timing: Prior to initiation and during dose titration.

Level of consciousness/sedation

Rationale: To assess baseline neurological status and identify risk for excessive sedation.

Timing: Prior to initiation and during dose titration.

Pain assessment (type, intensity, frequency of BTCP)

Rationale: To establish baseline pain and guide appropriate dosing and titration.

Timing: Prior to initiation.

Opioid tolerance status

Rationale: Fentanyl buccal tablets are only for opioid-tolerant patients. Verify daily opioid dose equivalent.

Timing: Prior to initiation.

πŸ“Š

Routine Monitoring

Respiratory rate and depth

Frequency: Regularly, especially during dose titration and after each dose for the first few doses.

Target: Normal for patient, no signs of respiratory depression (<10 breaths/min, shallow breathing)

Action Threshold: Significant decrease in respiratory rate, shallow breathing, cyanosis, somnolence. Administer naloxone if indicated.

Level of consciousness/sedation

Frequency: Regularly, especially during dose titration and after each dose.

Target: Alert and oriented, or easily aroused.

Action Threshold: Excessive sedation, somnolence, difficulty arousing. Reduce dose or hold next dose.

Pain relief and adverse effects

Frequency: After each dose for BTCP, and regularly during therapy.

Target: Adequate pain relief with tolerable side effects.

Action Threshold: Inadequate pain relief (consider dose increase), or intolerable side effects (consider dose reduction or alternative).

Bowel function

Frequency: Daily/regularly

Target: Regular bowel movements

Action Threshold: Constipation. Initiate or adjust laxative regimen.

πŸ‘οΈ

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing)
  • Excessive sedation/somnolence
  • Dizziness
  • Nausea/vomiting
  • Constipation
  • Confusion
  • Miosis (pinpoint pupils)
  • Itching
  • Signs of opioid withdrawal (if abruptly discontinued)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy is generally not recommended unless the potential benefit justifies the potential risk to the fetus. Prolonged use can lead to neonatal opioid withdrawal syndrome.

Trimester-Specific Risks:

First Trimester: Potential for increased risk of congenital malformations, though data are limited and conflicting for opioids in general.
Second Trimester: Risk of fetal growth restriction and adverse neurodevelopmental outcomes.
Third Trimester: Risk of neonatal opioid withdrawal syndrome (NOWS) in the newborn, characterized by irritability, hyperactivity, abnormal sleep pattern, high-pitched cry, tremor, vomiting, diarrhea, and weight loss. Also risk of respiratory depression in the neonate if used close to delivery.
🀱

Lactation

Fentanyl is excreted into breast milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., sedation, respiratory depression), breastfeeding is not recommended during treatment with fentanyl buccal tablets. If breastfeeding cannot be avoided, monitor the infant closely for signs of sedation and respiratory depression.

Infant Risk: L4 (Potentially hazardous)
πŸ‘Ά

Pediatric Use

Safety and efficacy have not been established in pediatric patients under 18 years of age. Accidental ingestion in children can be fatal. Strict storage and disposal precautions are essential.

πŸ‘΄

Geriatric Use

Elderly patients may be more sensitive to the effects of fentanyl, particularly respiratory depression. Use with caution, consider lower initial doses, and titrate slowly. Monitor closely for adverse effects.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fentanyl buccal tablets are ONLY for opioid-tolerant patients with breakthrough cancer pain. It is NOT for opioid-naive patients or for acute pain.
  • Strict adherence to the TIRF REMS Access program is mandatory for prescribing, dispensing, and patient enrollment.
  • Dosing is individualized and requires careful titration. Do not convert from other fentanyl products on a mcg-per-mcg basis due to different absorption profiles.
  • Patients should be instructed to place the tablet in the buccal cavity (between gum and cheek) or sublingually and allow it to dissolve completely without chewing, crushing, or swallowing.
  • Educate patients and caregivers on the signs of respiratory depression and the importance of immediate medical attention and naloxone administration if an overdose is suspected.
  • Emphasize secure storage and proper disposal (flushing down the toilet) to prevent accidental exposure, especially to children.
  • Monitor for drug interactions, particularly with CYP3A4 inhibitors, which can significantly increase fentanyl levels and risk of toxicity.
πŸ”„

Alternative Therapies

  • Other short-acting opioids for breakthrough pain (e.g., immediate-release oxycodone, hydromorphone, morphine)
  • Non-opioid analgesics (for non-cancer pain or as adjuncts)
  • Adjuvant analgesics (e.g., gabapentin, pregabalin, tricyclic antidepressants for neuropathic pain)
πŸ’°

Cost & Coverage

Average Cost: Varies widely by strength and brand/generic per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 3 or 4 (Specialty/Non-preferred Brand/Generic), often requires prior authorization and adherence to REMS program.
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which provides crucial information about its safe use. It is essential to read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for clarification.

In the event of an overdose, a medication called naloxone can be used as an emergency treatment. Discuss the availability and use of naloxone with your doctor or pharmacist. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. When seeking help, be prepared to provide information about the medication taken, the amount, and the time it was taken.

In case of a suspected overdose, contact your local poison control center or seek emergency medical care right away. When reporting the incident, be prepared to provide detailed information about the medication, including the amount taken and the time of ingestion.